Abstract PS4-07-02: Determinants of early and late relapse in patients with early triple negative breast cancer from the prospective CANTO Cohort

Clinical Cancer Research 2026

View at publisher
Authors: C. Benvenuti, L. Perotti, Anne-Laure MARTIN, Catherine Gaudin, Christelle Jouannaud, M. Fournier, Courèche Kaderbhaï, Anne Kieffer, François Cherifi, Mario Campone, F. Lerebours, Paul Henri Cottu
+6 more Fabrice André, Aurélie Bertaut, D. Antonio, Stefan Michiels, B. Pistilli, Thomas Grinda
DOI: 10.1158/1557-3265.sabcs25-ps4-07-02
Cited by: 0

Abstract

Abstract Background: TNBC exhibits a high risk of early relapse, yet predictors of time to relapse remain poorly defined. Early relapses (while on or within 12 months after ending curative therapies) are associated with chemotherapy-resistant disease and poor prognosis (median overall survival

Fields of Study & Subjects

Breast Cancer Treatment Studies Breast Lesions and Carcinomas MRI in cancer diagnosis

Publication details

Journal / source
Clinical Cancer Research
Volume
32
Issue
4_Supplement
Pages
PS4–07
Publication date
17 February 2026
Language
EN